TScan Therapeutics, Inc. Share Price
NASDAQ: TCRX | Micro CapTScan Therapeutics, Inc. Stock Performance
TScan Therapeutics, Inc. Share Price Today
As of 31 October 2026, TScan Therapeutics, Inc.'s share price is $0.17. The stock opened at $0.19, compared to its previous close of $0.19. During today's trading session, TScan Therapeutics, Inc.'s share price traded between $0.18 and $0.19, with an average price of $0.18. Over the past 52 weeks, the stock has recorded a high of $2.01 and a low of $0.18. In terms of performance, TScan Therapeutics, Inc.'s share price has declined by 85.08% over the last six months and is down 91.00% on a year-on-year basis.
TScan Therapeutics, Inc. Share Price Chart
TScan Therapeutics, Inc. Quarterly Profit & Loss
All figures in USD
TScan Therapeutics, Inc. Annual Profit & Loss
All figures in USD
About TScan Therapeutics, Inc.
TScan Therapeutics Inc is a fully integrated clinical-stage biotechnology company focused on developing a robust pipeline of T cell receptor (TCR)-engineered T cell, or TCR-T, therapies for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.
TScan Therapeutics, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $0.32 | $0.17 | -45.63% |
Sep 2026 | $0.71 | $0.32 | -57.67% |
Aug 2026 | $0.75 | $0.76 | +1.34% |
Jul 2026 | $1.02 | $0.75 | -23.88% |
Jun 2026 | $1.07 | $0.98 | -9.68% |
May 2026 | $1.14 | $1.08 | -7.26% |
Apr 2026 | $1.04 | $1.17 | +16.53% |
Mar 2026 | $1.07 | $1.00 | -5.73% |
Feb 2026 | $1.04 | $1.06 | +3.90% |
Jan 2026 | $1.00 | $1.02 | +3.02% |
Dec 2025 | $1.11 | $0.99 | -11.16% |
Nov 2025 | $1.44 | $1.12 | -42.27% |